Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR - Broekmans,F.J.; Bernardus,R.E.; Berkhout,G.; Schoemaker,J. (Gynecol Endocrinol, 1992)